Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 7,203	$ 16,913
Restricted cash	13,417	13,829
Accounts receivable, net	7,586	6,114
Prepaid expenses and other assets	5,008	4,099
Derivative assets	1,600	2,611
Total current assets	34,814	43,566
Property and equipment, net	606,069	615,754
Other assets, net	1,226	1,948
Total assets	642,109	661,268
Current liabilities:
Accounts payable	10,005	7,272
Accrued expenses	36,008	36,944
Current portion of notes payable, net of deferred loan costs	88,636	46,029
Deferred income	4,142	3,419
Federal and state income taxes payable	61	0
Other current liabilities	554	653
Total current liabilities	139,406	94,317
Notes payable, net of deferred loan costs and current portion	547,381	625,002
Other liabilities	77	113
Total liabilities	686,864	719,432
Commitments and contingencies
Redeemable preferred stock:
Series A convertible preferred stock, $0.01 par value; 41 shares authorized, 41 shares issued and outstanding as of June 30, 2023 and December 31, 2022	45,978	43,550
Shareholders’ deficit:
Authorized shares - 15,000 as of June 30, 2023 and December 31, 2022; none issued or outstanding, except Series A convertible preferred stock as noted above	0	0
Authorized shares - 15,000 as of June 30, 2023 and December 31, 2022; 7,178 and 6,670 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	72	67
Additional paid-in capital	294,320	295,277
Retained deficit	(385,125)	(397,058)
Total shareholders’ deficit	(90,733)	(101,714)
Total liabilities, redeemable preferred stock and shareholders’ deficit	$ 642,109	$ 661,268